BOSTON – More than 4,000 leading researchers and clinicians from around the world will convene in Boston, Massachusetts from Feb. 27 through March 2 for the 18th Conference on Retroviruses and Opportunistic Infections (CROI).
CROI is a scientifically focused meeting of the world’s leading researchers working to understand, prevent and treat HIV/AIDS and its complications. The goal of CROI is to provide a forum for translating laboratory and clinical research into progress against the AIDS epidemic.
The objective of the conference is to bring together the leaders in disparate, but interrelated areas of AIDS research to interact with and educate one another in the very latest results, treatment methods and state of the art technological advances.
The need for continued research on HIV/AIDS is clear. More than 30 million people worldwide are infected with HIV, with millions of new infections each year. The research efforts of tens of thousands of scientists and clinicians have had considerable success in diagnosing and treating infection. Nevertheless, we still do not have either a curative treatment or a preventive vaccine, without which most of those presently infected will die of AIDS, and new infections will continue unabated.
CROI recognizes that timely communication of the results of such research among scientists and clinicians working on this subject is critical to advancing the field as rapidly as possible.
